• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

1992年至1996年间从菌血症或脑膜炎患者中分离出的B族链球菌的抗菌药敏情况。

Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.

作者信息

Fernandez M, Hickman M E, Baker C J

机构信息

Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA.

出版信息

Antimicrob Agents Chemother. 1998 Jun;42(6):1517-9. doi: 10.1128/AAC.42.6.1517.

DOI:10.1128/AAC.42.6.1517
PMID:9624508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC105636/
Abstract

In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.

摘要

对来自各类侵袭性感染患者的229株B族链球菌分离株进行的体外试验表明，这些菌株对青霉素G均敏感。然而，有17株（7.4%）分离株对红霉素耐药，8株（3.4%）对克林霉素耐药。这些结果支持继续将青霉素G作为治疗和预防B族链球菌病的首选药物。

相似文献

1
Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis.1992年至1996年间从菌血症或脑膜炎患者中分离出的B族链球菌的抗菌药敏情况。
Antimicrob Agents Chemother. 1998 Jun;42(6):1517-9. doi: 10.1128/AAC.42.6.1517.
2
Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents.278株链球菌血培养分离株对七种抗菌药物的药敏情况
J Antimicrob Chemother. 1997 Feb;39(2):135-40. doi: 10.1093/oxfordjournals.jac.a020858.
3
Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease: 10-year perspective.侵袭性疾病患者分离出的B族链球菌的抗菌药敏性：十年回顾
Antimicrob Agents Chemother. 2001 Dec;45(12):3623-4. doi: 10.1128/AAC.45.12.3623-3624.2001.
4
Anti-microbial susceptibility of Streptococcus spp. isolated from bovine mastitis in Argentina.从阿根廷患乳腺炎的奶牛中分离出的链球菌属的抗菌药敏性。
J Vet Med B Infect Dis Vet Public Health. 2005 Apr;52(3):125-8. doi: 10.1111/j.1439-0450.2005.00830.x.
5
Nosocomial streptococcal blood stream infections in the SCOPE Program: species occurrence and antimicrobial resistance. The SCOPE Hospital Study Group.SCOPE项目中的医院获得性链球菌血流感染：菌种分布及抗菌药物耐药性。SCOPE医院研究小组。
Diagn Microbiol Infect Dis. 1997 Dec;29(4):259-63. doi: 10.1016/s0732-8893(97)00159-4.
6
Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci.青霉素G与庆大霉素联合使用对耐青霉素的草绿色链球菌的活性增强。
Antimicrob Agents Chemother. 1995 Dec;39(12):2816-8. doi: 10.1128/AAC.39.12.2816.
7
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.从癌症中性粒细胞减少患者血液中分离出的草绿色链球菌的分子关系及抗菌药敏性
J Clin Microbiol. 1999 Jun;37(6):1876-80. doi: 10.1128/JCM.37.6.1876-1880.1999.
8
Oral streptococcal strains isolated from odontogenic infections and their susceptibility to antibiotics.从牙源性感染中分离出的口腔链球菌菌株及其对抗生素的敏感性。
Rev Med Chir Soc Med Nat Iasi. 2006 Oct-Dec;110(4):1012-5.
9
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.在西班牙，莫西沙星与其他抗菌药物对从医源性口腔菌血症中分离出的链球菌的体外活性比较。
Oral Microbiol Immunol. 2004 Oct;19(5):331-5. doi: 10.1111/j.1399-302x.2004.00167.x.
10
Antibiotic susceptibility pattern and erythromycin resistance mechanisms in beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis isolates from central Taiwan.台湾中部地区β-溶血性G群似马链球菌亚种分离株的抗生素敏感性模式及红霉素耐药机制
J Microbiol Immunol Infect. 2015 Dec;48(6):613-7. doi: 10.1016/j.jmii.2014.04.003. Epub 2014 May 22.

引用本文的文献

1
Evolving antibiotic resistance in Group B Streptococci causing invasive infant disease: 1970-2021.B 群链球菌导致侵袭性婴儿疾病的抗生素耐药性演变：1970-2021 年。
Pediatr Res. 2023 Jun;93(7):2067-2071. doi: 10.1038/s41390-022-02375-3. Epub 2022 Nov 9.
2
Population Genomics Reveals Distinct Temporal Association with the Emergence of ST1 Serotype V Group B Streptococcus and Macrolide Resistance in North America.人群基因组学揭示了 ST1 血清型 V 组乙型链球菌和北美的大环内酯类耐药性的出现具有明显的时间关联。
Antimicrob Agents Chemother. 2022 Jan 18;66(1):e0071421. doi: 10.1128/AAC.00714-21. Epub 2021 Oct 11.
3
Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection.分娩期间使用阴道氯己定预防早发型新生儿B族链球菌感染。
Cochrane Database Syst Rev. 2014 Dec 14;2014(12):CD003520. doi: 10.1002/14651858.CD003520.pub3.
4
Streptococcus agalactiae in adults at Chiang Mai University Hospital: a retrospective study.成人中停乳链球菌感染：一项回顾性研究。
BMC Infect Dis. 2011 May 25;11:149. doi: 10.1186/1471-2334-11-149.
5
Group B Streptococcus prophylaxis in patients who report a penicillin allergy: a follow-up study.青霉素过敏患者的 B 型链球菌预防：一项随访研究。
Am J Obstet Gynecol. 2011 Feb;204(2):150.e1-8. doi: 10.1016/j.ajog.2010.08.063. Epub 2010 Dec 17.
6
Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.急性细菌性脑膜炎的流行病学、诊断和抗菌治疗。
Clin Microbiol Rev. 2010 Jul;23(3):467-92. doi: 10.1128/CMR.00070-09.
7
Antibiotic resistance patterns in invasive group B streptococcal isolates.侵袭性B族链球菌分离株的抗生素耐药模式
Infect Dis Obstet Gynecol. 2008;2008:727505. doi: 10.1155/2008/727505. Epub 2009 Feb 5.
8
Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility.青霉素敏感性降低的临床分离B族链球菌中pbp基因的遗传异质性。
Antimicrob Agents Chemother. 2008 Dec;52(12):4258-67. doi: 10.1128/AAC.00596-08. Epub 2008 Sep 22.
9
Pharmacokinetics of penicillin g in very-low-birth-weight neonates.青霉素G在极低出生体重儿中的药代动力学
Antimicrob Agents Chemother. 2007 Jun;51(6):1995-2000. doi: 10.1128/AAC.01506-06. Epub 2007 Mar 19.
10
Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts.来自牛和人类宿主的无乳链球菌分离株的血清型分布及抗菌耐药基因情况。
J Clin Microbiol. 2005 Dec;43(12):5899-906. doi: 10.1128/JCM.43.12.5899-5906.2005.

本文引用的文献

1
A SEROLOGICAL DIFFERENTIATION OF SPECIFIC TYPES OF BOVINE HEMOLYTIC STREPTOCOCCI (GROUP B).牛溶血性链球菌（B 群）的血清学分型鉴别。
J Exp Med. 1934 Mar 31;59(4):441-58. doi: 10.1084/jem.59.4.441.
2
Susceptibility of hemolytic streptococci, other than those of group D, to eleven antibiotics in vitro.除D组以外的溶血性链球菌在体外对11种抗生素的敏感性
Am J Clin Pathol. 1957 Feb;27(2):159-69. doi: 10.1093/ajcp/27.2.159.
3
Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994.1992年至1994年间获得的B族链球菌和大肠杆菌的阴道及胎盘分离株对氨苄西林的敏感性
Antimicrob Agents Chemother. 1997 May;41(5):1173-4. doi: 10.1128/AAC.41.5.1173.
4
High incidence of erythromycin-resistant streptococci in Taiwan.台湾地区红霉素耐药性链球菌的高发病率。
Antimicrob Agents Chemother. 1997 Apr;41(4):844-6. doi: 10.1128/AAC.41.4.844.
5
Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn.预防早发性B族链球菌（GBS）感染的修订指南。美国儿科学会传染病委员会和胎儿与新生儿委员会。
Pediatrics. 1997 Mar;99(3):489-96. doi: 10.1542/peds.99.3.489.
6
Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention.围产期B族链球菌疾病的预防：公共卫生视角。疾病控制与预防中心。
MMWR Recomm Rep. 1996 May 31;45(RR-7):1-24.
7
Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group.将耐多药肺炎链球菌（DRSP）的影响降至最低。DRSP工作组提出的一项策略。
JAMA. 1996 Jan 17;275(3):206-9.
8
Invasive group B streptococcal disease: the emergence of serotype V.侵袭性B族链球菌病：血清型V的出现。
J Infect Dis. 1996 Feb;173(2):365-73. doi: 10.1093/infdis/173.2.365.
9
Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci.B族链球菌临床分离株中的抗生素耐药性和青霉素耐受性
Antimicrob Agents Chemother. 1994 Sep;38(9):2183-6. doi: 10.1128/AAC.38.9.2183.
10
Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development.B族链球菌病的流行病学。危险因素、预防策略及疫苗研发。
Epidemiol Rev. 1994;16(2):374-402. doi: 10.1093/oxfordjournals.epirev.a036159.